---
layout: startup_page
title: "Edgewood Oncology"
id: "edgewoodoncology.com"
permalink: "/edgewoodoncologyedgewoodoncology.com04022025/"
website: "https://edgewoodoncology.com/"
funding_round: "Series A"
funding_amount: "$20M"
investors: "Alta Partners"
about: "Edgewood Oncology is a clinical-stage biotechnology company focused on advancing BTX-A51, a novel small molecule, multi-kinase inhibitor, for patients with hematologic malignancies and genetically-defined solid tumors. BTX-A51 works by synergistically co-targeting master regulators of cancer to promote cell death. The company is currently conducting Phase 2a studies in acute myeloid leukemia and plans to begin a breast cancer study in Q2 2024."
markets: "Biotechnology, Oncology, Pharmaceutical, Drug Discovery, HealthTech, Life Sciences"
hq: "Brookline, Massachusetts, United States"
founded_year: "2022"
linkedin: "https://www.linkedin.com/company/edgewood-oncology"
twitter: ""
instagram: ""
facebook: ""
crunchbase: "https://www.crunchbase.com/organization/edgewood-oncology?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase"
pitchbook: "https://pitchbook.com/profiles/company/592299-55"

# SEO Optimization
meta_title: "Edgewood Oncology - Series A Funding ($20M)"
meta_description: "Edgewood Oncology, Edgewood Oncology is a clinical-stage biotechnology company focused on advancing BTX-A51, a novel small molecule, multi-kinase inhibitor, for patients..."
meta_keywords: "Edgewood Oncology, Biotechnology, Oncology, Pharmaceutical, Drug Discovery, HealthTech, Life Sciences, Series A funding"
canonical_url: "https://pkprojectstartups.github.io/projectstartups.com/edgewoodoncologyedgewoodoncology.com04022025/"
---